Informa Life Sciences, market leader in providing quality, expert-led conferences ,will be organising the event “Clinical Trials in Emerging Economies 2010” on June 29 and 30, 2010 at Sheraton, Brussels City Centre, Belgium.

Though the number of clinical trials being run in emerging economic areas has grown significantly in recent years, there are a number of challenges to overcome when planning these trials. The EMA is now asking for in-depth, prospective analysis of potential ethnic factors” in clinical trials performed outside the EU. Additionally, managing the timelines, costs and quality of studies can be problematic.

Participating in “Clinical Trials in Emerging Economies 2010” will help a delegate to make the most of the opportunities available.

Informa Life Sciences, panel of experts will be providing the participants with crucial industry knowledge for success in running trials abroad. The agenda has been researched with leading figures within the clinical trials industry and addressing the key challenges encountered in this area.

Benefits of attending the programme include: Examine how the market will evolve as established countries adjust their regulatory framework and newer regions develop the infrastructure needed to support trials; Discover which areas will be future hubs of development and identify the optimal location for trials; Overcoming the challenges of shipping clinical trial supplies to remote regions and obtaining import and export licenses.; Manage timelines: Being prepared for possible bottlenecks in development to streamline running of clinical trials; Being aware of possible cultural and language barriers to development and hear strategies for implementation of GCP; Learning how to ensure that data obtained abroad is valid for domestic drug licensing.

This year’s agenda includes case studies to provide the participants with valuable knowledge for success in India, China, Latin America, Middle East, Africa, Central and Eastern Europe and South East Asia.
 
Expert speaker panel includes: Dr Shibadas Biswal, Clinical Trial Leader, Translational Medicine, Novartis, India; Dr Luis Rios Nogales Garces, ISMO, Head, MCCD Clinical Research Region Regional Medical Director, AstraZeneca, Latin America; Dr Yan Wu, Medical and Clinical Development Director, Biogen Idec, China; Dr Diane Driver, Senior Director, Global Head Clinical Site Management and Monitoring, UCB Celltech, UK; Dr Viraj Rajadhyaksha, Senior Manager, Operations, Planning and Management, Clinical Research, Pfizer, India; Dr Daniela Popescu, Clinical Trials Manager, Roche, Romania; Dr. Nirjhar Chatterjee, Director, Global Medical Affairs- Paediatric Vaccines, Head DTP, Polio & Meningitis Vaccines, GlaxoSmithKline Biologicals, Belgium; Dr François Simon, Regional Head Clinical Monitoring International, Middle East, Africa, Asia , Pacific, Merck Serono , Switzerland; Professor Johan Karlberg, Leader of Clinical Trial Centre, Medical University of Hong Kong, China; Dr Jorg J Mohrle, Director Clinical Development, Medicines for Malaria Venture, Switzerland; Dr Heinrich Klech, Professor of Medicine, CEO and Executive Vice President, Vienna School of Clinical Research, Austria; Professor Ifeoma Okoye, Chairman, Association for Good Clinical Practice in Nigeria, Nigeria.

The pre-conference workshop on June 28 is “Key factors in choosing the most cost-effective region for your study” led by Dr Hoda Tawfik, Director Global Clinical Operations, MediGene AG,Germany.

The pre conference evening seminar on June 28 is “Essential guidance on working with outsourcing partners in emerging economies led by: Roger Joby, Director, 1to1, UK.

For further details vist: http://www.informaglobalevents.com/event/emergingeconomies/booking/form/368